Valganciclovir is safe and effective as pre-emptive therapy for CMV infection in allogeneic hematopoietic stem cell transplantation (Q46987210)
scientific article published in May 2006
Language:
(P31) (Q13442814)
(P304) 851-856
(P407) (Q1860)
(P433) 9
(P478) 37
(P577) Monday, May 1, 2006
(P921) (Q423384)
(P1433) (Q4941523)
(P1476) "Valganciclovir is safe and effective as pre-emptive therapy for CMV infection in allogeneic hematopoietic stem cell transplantation" (language: en)
(P2093) E Ayala
J Greene
R Sandin
J Perkins
T Field
C Tate
K K Fields
S Goldstein
(P2860) (Q33972690)
(Q43904524)
(Q43613345)
(Q34785629)
(Q34722706)
(Q47573431)
(Q36093289)
(Q43955899)
(Q43710395)
(Q34439235)
(Q33340924)
(Q77658507)
(Q61053494)
(Q74152230)
(Q73322562)
(Q72940232)
(Q72940234)
(Q68262204)
(Q73310627)
other details
description scientific article published in May 2006

External Links